HC Wainwright Boosts Earnings Estimates for Bausch + Lomb

Key Points

• HC Wainwright raised its earnings forecasts for Bausch + Lomb, lifting Q4 2026 EPS to $0.34 from $0.28 and projecting FY2027 EPS of $1.05. It maintained a Neutral rating and a $22 price target.
• Bausch + Lomb reported quarterly EPS of $0.34, beating the $0.21 consensus, while revenue of $1.38 billion topped estimates and rose 7.3% year over year.
• Insider selling was notable: Chief Accounting Officer Frederick Munsch sold 112,015 shares for about $2.29 million, reducing his holdings by roughly 71%.

Bausch + Lomb Corporation (NYSE:BLCO - Free Report) - HC Wainwright boosted their Q4 2026 earnings per share estimates for Bausch + Lomb in a report released on Monday, November 2nd. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per share of $0.34 for the quarter, up from their previous estimate of $0.28. HC Wainwright has a "Neutral" rating and a $22.00 price objective on the stock. The consensus estimate for Bausch + Lomb's current full-year earnings is $0.94 per share. HC Wainwright also issued estimates for Bausch + Lomb's Q3 2027 earnings at $0.25 EPS, Q4 2027 earnings at $0.35 EPS and FY2027 earnings at $1.05 EPS.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.13. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.37 billion. Bausch + Lomb had a positive return on equity of 5.01% and a negative net margin of 2.05%. The firm's revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.18 earnings per share.

BLCO has been the subject of several other research reports. Weiss Ratings upgraded shares of Bausch + Lomb from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 21st. Zacks Research upgraded Bausch + Lomb from a "hold" rating to a "strong-buy" rating in a report on Friday, October 30th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $20.00 price objective on shares of Bausch + Lomb in a report on Thursday, October 29th. JPMorgan Chase & Co. lifted their target price on Bausch + Lomb from $16.00 to $22.00 and gave the company a "neutral" rating in a research report on Thursday, October 29th. Finally, Barclays raised shares of Bausch + Lomb to a "strong-buy" rating in a report on Wednesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $20.83.

Bausch + Lomb Stock Performance

NYSE BLCO opened at $20.01 on Wednesday. Bausch + Lomb has a 12 month low of $14.44 and a 12 month high of $21.36. The company has a current ratio of 1.56, a quick ratio of 1.04 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $7.15 billion, a PE ratio of -64.55, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The business's 50-day moving average price is $17.46 and its two-hundred day moving average price is $16.71.

Institutional Investors Weigh In On Bausch + Lomb

Several large investors have recently added to or reduced their stakes in BLCO. Whitebox Advisors LLC increased its holdings in shares of Bausch + Lomb by 15.8% in the 1st quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company's stock worth $17,519,000 after buying an additional 150,641 shares during the last quarter. Beach Point Capital Management LP bought a new stake in shares of Bausch + Lomb in the 3rd quarter valued at about $5,882,000. Sei Investments Co. lifted its position in Bausch + Lomb by 100.0% in the first quarter. Sei Investments Co. now owns 139,266 shares of the company's stock valued at $2,214,000 after purchasing an additional 69,633 shares during the last quarter. Engineers Gate Manager LP purchased a new stake in Bausch + Lomb during the 2nd quarter valued at $1,479,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Bausch + Lomb by 13.2% during the first quarter. Dimensional Fund Advisors LP now owns 85,779 shares of the company's stock worth $1,362,000 after purchasing an additional 9,971 shares during the period. Institutional investors own 11.07% of the company's stock.

Insider Activity at Bausch + Lomb

In related news, CAO Frederick Munsch sold 112,015 shares of Bausch + Lomb stock in a transaction that occurred on Thursday, October 29th. The shares were sold at an average price of $20.48, for a total value of $2,294,067.20. Following the completion of the transaction, the chief accounting officer directly owned 45,831 shares in the company, valued at approximately $938,618.88. The trade was a 70.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Eschenbach Andrew C. Von sold 12,500 shares of Bausch + Lomb stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $16.50, for a total value of $206,250.00. Following the completion of the transaction, the director owned 69,792 shares of the company's stock, valued at approximately $1,151,568. This trade represents a 15.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 183,474 shares of company stock valued at $3,488,437. 1.45% of the stock is owned by insiders.

Key Bausch + Lomb News

Here are the key news stories impacting Bausch + Lomb this week:

• Positive Sentiment: Analyst earnings estimates increased: HC Wainwright raised its forecasts for Q4 2026 EPS to $0.34 from $0.28 and FY2027 EPS to $1.05 from $0.89. It also lifted estimates for Q3 and Q4 2027. Higher projections suggest improving expectations for future earnings.
• Neutral Sentiment: Rating remains cautious: Despite the estimate increases, HC Wainwright kept its Neutral rating and $22 price target after recently downgrading BLCO from Buy. The target is above the $20.01 reference price, but the rating signals limited conviction in outperformance. Bausch + Lomb Stock Rating Lowered by HC Wainwright
• Negative Sentiment: Significant insider sale: Chief Accounting Officer Frederick Munsch sold 112,015 shares for about $2.29 million, cutting his reported holdings by roughly 71%. The sale could weigh on sentiment, although insider transactions do not necessarily indicate a negative outlook. Bausch + Lomb CAO Sells Shares

Bausch + Lomb Company Profile

Bausch + Lomb Corporation NYSE: BLCO is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.